Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
intravenous TB-4 Phase 1 safety and pharmacokinetics, no dose-limiting or serious adverse events (Ann N Y Acad Sci 2010;1194:223229): NCT00743769 Centers for Disease Control and Prevention
Microneedling the scalp before AHK-Cu application can substantially improve penetration
Progress photos
The peptide sits on the skins surface
Redness, itching, or mild irritation at the application site can occur, particularly during initial use or with higher concentrations
US$ 21.92
US$ 29.96
US$ 29.73
US$ 23.96
US$ 28.08
US$ 23.80
US$ 29.95
US$ 28.81
